Equity Profile

LMAT

LeMaitre Vascular, Inc.

Health CareHealth Care Equipment$1.9B

Aug10Mon

Pre-Earnings Brief

UpcomingQ2-2026After Close5:00 PM EDT

Company Snapshot

LeMaitre Vascular, Inc. (LMAT) operates in the health care sector, focusing on medical devices for vascular surgery....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and financial health, which investors closely watch.

$0.70

Revenue

Revenue growth reflects the company's ability to increase sales and expand its market presence.

$68M

Wall Street expectations, options signals, track record, and call prep available with Pro.

LMAT Q2-2026 Earnings Preview

Context

Company Snapshot

LeMaitre Vascular, Inc. (LMAT) operates in the health care sector, focusing on medical devices for vascular surgery. With a market cap of $2 billion, the company plays a crucial role in providing innovative solutions for patients with vascular diseases.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+4.17%

Avg Stock Reaction

-0.41%

Last Quarter Recap

In Q1-2026, LeMaitre reported an EPS of $0.68, beating estimates by 2.56%. The stock reacted positively, gaining 0.42% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect LeMaitre to report solid earnings, with a consensus EPS of $0.70 and revenue of $68 million. Investors are keen to see if the company can maintain its growth trajectory.

Bull Case

If LeMaitre beats earnings expectations, it could signal strong demand for its products and potentially lead to a higher stock price.

Bear Case

Conversely, if the company misses expectations, it may raise concerns about its growth prospects and lead to a decline in stock value.

Key Metrics to Watch

EPS

$0.70

Earnings per share is a key indicator of profitability and financial health, which investors closely watch.

Revenue

$68M

Revenue growth reflects the company's ability to increase sales and expand its market presence.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $0.70?

A beat on EPS could indicate stronger profitability and market demand, which would be positively received by investors.

What revenue figures will LeMaitre report compared to the $68 million consensus?

Revenue performance is critical for assessing growth and market position, and a miss could raise concerns about future sales.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate LeMaitre's ability to capitalize on recent product innovations, which could drive higher-than-expected revenue.

Supporting Evidence

The company has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.

Options pricing suggests a higher expected move than historical averages, indicating potential for significant stock movement.

The recent positive trends in the health care sector could benefit LeMaitre more than anticipated.

Key Risk

If revenue comes in significantly above $68 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial as it will reflect the company's ability to sustain growth amidst market challenges.

Bull Confirmed If

Reporting EPS above $0.70 with revenue exceeding $68 million would confirm strong operational performance.

Bear Confirmed If

An EPS below $0.68 or revenue below $67 million would suggest weakening demand and could lead to a stock decline.

Pre-Earnings Positioning

Options Market

Implied Move

±3.08%

Historical Avg

±1.1%

Pricing rich

The options market is pricing in a move of about 3.08%, indicating that traders expect some volatility around the earnings report.

Options are pricing ±3.1% while LMAT has averaged ±1.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.4%

Calls (0)P/C Ratio: 12.00Puts (3K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LeMaitre beats expectations, history suggests the stock could rise around 0.06% on average the next day, confirming bullish sentiment.

In-Line / Cautious

An in-line report may lead to muted reactions as investors await further commentary from management.

Miss

If the company misses expectations, history suggests a potential decline of about 1.80% on average the next day, which could raise concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Management's outlook on market demand for vascular products.
3Details on cost management strategies and their effect on margins.
4Insights into competitive pressures and how the company plans to address them.
5Any commentary on international sales growth and expansion plans.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Tempus AI, Inc.

Company Snapshot

LeMaitre Vascular, Inc. (LMAT) operates in the health care sector, focusing on medical devices for vascular surgery....

Key Metrics to Watch

EPS

Earnings per share is a key indicator of profitability and financial health, which investors closely watch.

$0.70

Revenue

Revenue growth reflects the company's ability to increase sales and expand its market presence.

$68M

Wall Street expectations, options signals, track record, and call prep available with Pro.

LMAT Q2-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+4.17%

Avg Stock Reaction

-0.41%

Last Quarter Recap

In Q1-2026, LeMaitre reported an EPS of $0.68, beating estimates by 2.56%. The stock reacted positively, gaining 0.42% the following day.

Management Promises & Guidance

Expectations

Wall Street Expectations

Analysts expect LeMaitre to report solid earnings, with a consensus EPS of $0.70 and revenue of $68 million. Investors are keen to see if the company can maintain its growth trajectory.

Bull Case

If LeMaitre beats earnings expectations, it could signal strong demand for its products and potentially lead to a higher stock price.

Bear Case

Conversely, if the company misses expectations, it may raise concerns about its growth prospects and lead to a decline in stock value.

Key Metrics to Watch

EPS

$0.70

Earnings per share is a key indicator of profitability and financial health, which investors closely watch.

Revenue

$68M

Revenue growth reflects the company's ability to increase sales and expand its market presence.

Expectations

Two Questions That Matter

The print will turn on these two things.

Will EPS exceed the consensus estimate of $0.70?

A beat on EPS could indicate stronger profitability and market demand, which would be positively received by investors.

What revenue figures will LeMaitre report compared to the $68 million consensus?

Revenue performance is critical for assessing growth and market position, and a miss could raise concerns about future sales.

Edge

What the Street Is Missing

Why consensus could be wrong

The Street may underestimate LeMaitre's ability to capitalize on recent product innovations, which could drive higher-than-expected revenue.

Supporting Evidence

The company has consistently beaten EPS estimates in recent quarters, indicating strong operational execution.

Options pricing suggests a higher expected move than historical averages, indicating potential for significant stock movement.

The recent positive trends in the health care sector could benefit LeMaitre more than anticipated.

Key Risk

If revenue comes in significantly above $68 million, it could challenge the current bearish sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance is crucial as it will reflect the company's ability to sustain growth amidst market challenges.

Bull Confirmed If

Reporting EPS above $0.70 with revenue exceeding $68 million would confirm strong operational performance.

Bear Confirmed If

An EPS below $0.68 or revenue below $67 million would suggest weakening demand and could lead to a stock decline.

Pre-Earnings Positioning

Options Market

Implied Move

±3.08%

Historical Avg

±1.1%

Pricing rich

The options market is pricing in a move of about 3.08%, indicating that traders expect some volatility around the earnings report.

Options are pricing ±3.1% while LMAT has averaged ±1.1% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.3%

30d HV

35.4%

Calls (0)P/C Ratio: 12.00Puts (3K)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

If LeMaitre beats expectations, history suggests the stock could rise around 0.06% on average the next day, confirming bullish sentiment.

In-Line / Cautious

An in-line report may lead to muted reactions as investors await further commentary from management.

Miss

If the company misses expectations, history suggests a potential decline of about 1.80% on average the next day, which could raise concerns about future growth.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Any updates on new product launches and their expected impact on sales.
2Management's outlook on market demand for vascular products.
3Details on cost management strategies and their effect on margins.
4Insights into competitive pressures and how the company plans to address them.
5Any commentary on international sales growth and expansion plans.